Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

implant

This page shows the latest implant news and features for those working in and with pharma, biotech and healthcare.

Medical devices probe uncovers need for “drastic regulatory changes”

Medical devices probe uncovers need for “drastic regulatory changes”

Reporters working on the Implant Files met in Washington, D.C. in 2018. ... Read the full report from t he International Consortium of Investigative Journalists (ICIJ) - The Implant Files.

Latest news

  • Boston Scientific makes $4.2bn play for UK’s BTG Boston Scientific makes $4.2bn play for UK’s BTG

    Boston Scientific is arguably best known for its cardiovascular stents, which hold open blood vessels cleared using angioplasty procedures, but also sells a broad range of surgical devices and implants.

  • Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more

    Scenesse (afamelanotide) has not been launched in the UK, but the company has stated that the cost of an implant will be £12, 020 (excluding VAT). ... The marketing authorisation recommends an implant is administered every two months before expected,

  • ABPI explores the future of medicines ABPI explores the future of medicines

    000 times smaller than a strand of hair to identify infection and inflammation in hip-implant patients.

  • 2018 by Darwin 2018 by Darwin

    It will punish, with extinction, those firms that either reject their implants or allow them to overpower routines, such as compliance, that are essential in our industry.

  • A unique ecosystem A unique ecosystem

    This enabled the launch of 27 innovative healthcare products. Examples include IRIMI, next-generation medical imaging services for hospitals; OsseoMatrix, a custom bone implant via direct 3D printing; and Biomodex, imaging

More from news
Approximately 1 fully matching, plus 86 partially matching documents found.

Latest Intelligence

  • Changes to look out for in Medical Devices Regulations Changes to look out for in Medical Devices Regulations

    PIP. In 2000, it was discovered that Poly Implant Prothèse (PIP) had been using industrial-grade silicone instead of the medical-grade specified for the CE mark in the manufacture of ... The CE mark for PIP implants was consequently withdrawn, and

  • Tightening medical device safety Tightening medical device safety

    Building on the lessons learned from recent events (such as the French PIP breast implant scandal), the EU regulations require that each device bears a unique device identifier (UDI) and that ... In this regard, medical device users of implantable

  • Deal Watch - May 2017 Deal Watch - May 2017

    its bupivacaine collagen implant for treatment of post-operative pain. ... Innocoll (US/IE). Gurnet Point (US). Company acquisition. Company with US pre-registration bupivacaine collagen implant for post-operative pain.

  • Here’s to all the bright sparks Here’s to all the bright sparks

    The first pacemaker implant took place just a few years later in 1958.

  • Deal Watch February 2017 Deal Watch February 2017

    In February, it granted North American rights to Zoladex, a goserelin acetate implant for prostate and breast cancer and benign gynaecological disorders, to US company TerSera Therapeutics. ... Licence. 358. AstraZeneca/ TerSera Therapeutics. Zoladex,

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Promimic appoints CEO Promimic appoints CEO

    Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development. ... Magnus brings valuable global leadership experience and a wide network from his time in the dental implant

  • Histogenics names former MedImmune president as CEO Histogenics names former MedImmune president as CEO

    This includes lead candidate NeoCart – a cartilage tissue implant in phase III trials.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Quick links

Infographics

Multimedia